Topics

AVXL On Track, INSM Breathes Easy, UTHR's Small Cell Lung Cancer Trial Fails

21:24 EST 3 Feb 2020 | RTTNews

Today's Daily Dose brings you news about the Fast Track Designation granted for Anavex Life Sciences' lead asset ANAVEX2-73; Insmed's phase II WILLOW study; Rockwell Medical's public offering of common stock and disappointing results from United Therapeutics' DISTINCT study.

Original Article: AVXL On Track, INSM Breathes Easy, UTHR's Small Cell Lung Cancer Trial Fails

NEXT ARTICLE

More From BioPortfolio on "AVXL On Track, INSM Breathes Easy, UTHR's Small Cell Lung Cancer Trial Fails"

Quick Search

Relevant Topic

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...